Crossmark

Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study

Crossref DOI link: https://doi.org/10.1007/s00467-018-3976-5

Published Online: 2018-09-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McMahon, Kelly R.

Harel-Sterling, Maya

Pizzi, Michael

Huynh, Louis

Hessey, Erin

Zappitelli, Michael
Funding

Funding for this research was provided by:

Fonds de Recherche du Québec - Santé

Kidney Research Scientist Core Education and National Training Program (KRESCENT)
License Information

Text and Data Mining valid from 2018-09-14
More Information

Article History

Received: 3 February 2018

Revised: 5 April 2018

Accepted: 7 April 2018

First Online: 14 September 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For the retrospective study component, formal consent was not required.

: Informed consent was obtained from all individual participants included in the study.